# Comparison Between Treatments of Oligohydramnios

> **NCT07135037** · PHASE2 · RECRUITING · sponsor: **Kafrelsheikh University** · enrollment: 40 (estimated)

## Conditions studied

- Oligohydramnios

## Interventions

- **DRUG:** Sildenafil 25 MG
- **DRUG:** L-Arginine, 1000 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT07135037
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135037, "Comparison Between Treatments of Oligohydramnios". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07135037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*